Initiator Pharma Gets UK CTA Approval For Phase 2a Study

RefinitivBacaan kurang dari 1 minit

Initiator Pharma A/S INIT:

RECEIVES UK CTA APPROVAL TO INITIATE PHASE 2A STUDY IN VULVODYNIA
FIRST PATIENTS EXPECTED TO BE ENROLLED IN Q4 2025

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini